Organisme : Société des tumeurs Carcinoïdes-NeuroEndocrines du Canada
	Projets financés à l'Université Laval
		Identifying the subgroups of GEP-NET patients that could benefit from temozolomide-induced upregulation of SSTR2 prior to PRRT
		Integrating Radiomics and Pathomics to Stratify Responders and Non-Responders to [177Lu]Lu-DOTA-TATE PRRT in Neuroendocrine Tumors